Haemophilus influenzae type b (Hib) seroprevalence in France: impact of vaccination schedules

BACKGROUND: Haemophilus influenzae serotype b (Hib) conjugate vaccine was introduced in France in 1992 as a 3 + 1 scheme at 2, 3, and 4 months (primary vaccination) with a booster at the age of 16–18 months. The vaccination was simplified in 2013 to a 2 + 1 scheme at 2 and 4 months (primary immuniza...

詳細記述

保存先:
書誌詳細
出版年:BMC Infect Dis
主要な著者: Hong, Eva, Terrade, Aude, Denizon, Mélanie, Aouiti-Trabelsi, Myriam, Falguières, Michaël, Taha, Muhamed-Kheir, Deghmane, Ala-Eddine
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2021
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC8325224/
https://ncbi.nlm.nih.gov/pubmed/34330228
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-021-06440-w
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料